GALDERMA
New global research,2 sponsored by Galderma and released today by leading filler brand Restylane®, has revealed the prevalent societal misconceptions and stereotypes facing the aesthetics industry. Forty percent of respondents admitted they would discourage others from using facial injectables to reduce wrinkles or provide volume. A further 34% said they believed the results of such treatments look fake and unnatural.
Despite holding these views, when the same respondents were presented with a range of images of people who had undergone filler treatments, the data told another story. On average, 4 out of 5 people could not always identify those who had received filler.3 This highlights the common misconceptions about these types of treatments and the results they deliver.
The perceptions surrounding the use of temporary fillers stand in stark contrast to those around the use of permanent beauty treatments such as tattoos, body piercings and dental corrections. Tattoos and body piercings are primarily seen as a positive form of self-expression (30% of respondents agreed for tattoos, and 24% for body piercings). Teeth straightening is viewed by 47% of respondents as a great way to enhance your appearance. Meanwhile, over a third of respondents (35%) believe fillers create unrealistic beauty standards and ideals, while 26% feel they can easily become addictive and 24% say they are an extreme option.
However, Restylane patient feedback data shows that 96% of people who used fillers felt their treatment exceeded expectations,4 and 95% of patients had maintained or enhanced the naturalness of their facial expressions after treatment.5,6
“This new research by Restylane highlights the perception that people are choosing procedures such as fillers because they lack confidence or are going to extremes to get their desired look. But this just isn’t the case! The vast majority of the clients I see are opting for small, subtle changes that will help them create their own look and feel empowered to be the best version of themselves. In my opinion, these people are inherently self-confident, know their own minds and are simply taking control of their own looks.”
DR. LUIZ AVELAR PLASTIC SURGEON BELO HORIZONTE, BRAZIL
|
The prevalence of societal judgements and the impact they have on how people behave are laid bare in the study. Only 11% of respondents said they would be supportive if a friend or family member told them they were considering using fillers. In contrast, according to Restylane patient feedback, 99% of those who have received treatment would recommend Restylane to a friend.4,6
Media leads in debunking misconceptions
The results also reveal that people see the media as more progressive in its views about aesthetic treatments. 27% percent of respondents said the media portrays injectables as empowering, while just 13% would personally describe them this way. Adult Gen Z7 respondents displayed a more open-minded attitude toward aesthetic procedures and were more likely to see treatments of this nature as empowering (19% in this age group agreed versus 13% overall). They were almost three times more likely to feel positively toward fillers than those over 55 years old, only 7% of whom agreed. Younger consumers also feel that people seeking injectable treatments are inherently more confident.
“I’m finding the newer generation is even more open-minded and interested when it comes to injectables. They consider aesthetic treatments to further define and enhance how they look and feel. Given that Restylane studies show that those who use dermal fillers feel overwhelmingly positive about their treatment, we are likely to see more people using them as a means of empowerment.”
STEVEN DAYAN, M.D. FACIAL PLASTIC SURGEON, PROFESSOR AND DIRECTOR OF DENOVA RESEARCH CHICAGO, ILLNOIS, U.S.
|
The research appears ahead of a Restylane product placement spot in new action-comedy film Mafia Mamma, directed by Catherine Hardwicke of Twilight fame and co-starring Toni Collette and Monica Bellucci. Mafia Mamma celebrates female empowerment and sees Toni Collette’s character challenging her comically clueless colleagues and their outdated attitudes about the reasons why women chose to undergo aesthetic treatments. While the film uses humor to highlight these stereotypes and the judgements people make about injectables, the attitudinal study highlights how these real-life judgements are still prevalent in society. Such beliefs have a tangible impact on the way people behave toward those considering fillers.
“We believe in championing everybody’s right to pursue their own beauty ideals. Our research findings are shining a spotlight on some of the misconceptions people have about aesthetic treatments. In this way, we hope to better equip people to make the decision that is right for them, without worrying about external pressures and judgements.”
GERRY MUHLE HEAD OF GLOBAL BUSINESS UNIT, AESTHETICS GALDERMA
|
About Restylane®
Restylane is the original non-animal stabilized hyaluronic acid filler with over 26 years of achievement and over 55 million treatments worldwide. NASHA™ and OBT™ technologies make Restylane the world’s most diverse range of fillers to deliver truly individualized results.4,5
The Restylane portfolio of products includes Restylane, Restylane Lyft™, Restylane Kysse™, Restylane Volyme™, Restylane® Defyne™, Restylane® Refyne™, Restylane® EYELIGHT™, Restylane SKINBOOSTERS™ VITAL and Restylane SKINBOOSTERS™ VITAL LIGHT.
About Galderma
Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story. For more information, visit: www.galderma.com.
Footnotes
1 Injectables are aesthetic products which are injected under the skin for a variety of reasons. These include relaxing muscles to alleviate facial wrinkles and folds, or helping contour areas of the face or body, e.g., by restoring volume or adding projection. They often come in the form of products such as botulinum toxin or HA-fillers.
2 Research was carried out by YouGov surveying 9,733 people across the UK, U.S., Canada, Brazil, Germany and Thailand between January 17 and 27, 2023.
3 Respondents were shown six images of people who had used dermal fillers and were asked to indicate if they think the person in the image had used dermal fillers.
4 Andriopoulos B, et al. Presented at: AMWC Monte Carlo, Monaco. 2019.
5 Phillipp-Dormston W, et al. J Cosmet Dermatol. 2020;19:1600–6.
6 Hilton S, et al. Dermatol Surg. 2018;44:261–9.6
7 Adult Gen Z includes those in the 18-24 age bracket.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230418006014/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Megaport Surpasses 1,000 Enabled Locations Worldwide7.8.2025 22:00:00 CEST | Press release
Megaport now provides access from 10% of all data centres worldwide, making it the world’s leading Network as a Service provider. Megaport Limited (ASX: MP1) (“Megaport”), the global leading Network as a Service (NaaS) provider, announced today that it has launched its 1,000th Megaport-enabled location. With this milestone, Megaport now provides access from 10% of all public data centres worldwide, making it the world’s leading vendor-neutral NaaS connectivity platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250807394677/en/ With over 1,000 enabled locations, Megaport now provides access from 10% of all data centres worldwide. From its start as a disruptor in the connectivity space, Megaport has now become the go-to solution for IT teams needing fast, flexible, and secure interconnection between cloud services, data centres, and enterprise sites. The Company’s global reach now spans over 160 cities across 26 countrie
Andersen Consulting indgår samarbejdsaftale med Systematix7.8.2025 21:38:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation og cybersikkerhed med tilføjelsen af samarbejdspartneren Systematix, et førende teknologikonsulentfirma, der er kendt for at levere innovative digitale løsninger, der bidrager til operationel effektivitet, vækst og konkurrencemæssige fordele. Systematix blev stiftet i 1975 og tilbyder komplette konsulent- og implementeringstjenester inden for digital transformation, udvikling af virksomhedsapplikationer, ERP, forretningsanalyse, it-strategi og cybersikkerhed. Med hundredvis af erfarne konsulenter og teknologer hjælper Systematix deres kunder med at navigere i komplekse forretningsmæssige udfordringer ved hjælp af nye teknologier og tilbyder skalerbare løsninger til en række robuste brancher, herunder finanssektoren, sundhedsvæsenet, produktionsvirksomheder og organisationer i den offentlige sektor. "I de sidste fem årtier har vi opbygget et omdømme for at levere robuste teknologiløsninger og ressourcer, der h
Lyten to Acquire All Remaining Northvolt Assets in Sweden and Germany7.8.2025 18:24:00 CEST | Press release
Lyten, the global leader in lithium-sulfur batteries, announced it has entered into binding agreements to acquire Northvolt Ett and Ett Expansion, Northvolt Labs, Northvolt Drei, and all remaining Northvolt intellectual property (IP). These newly acquired assets were previously valued at approximately $5B and include 16 GWh of operational battery production capacity and over 15 GWh under construction. Lyten has expressed interest in additionally acquiring Northvolt Six in Quebec, Canada. Lyten plans to restart operations at Northvolt Ett and Northvolt Labs upon close of the transaction, which is being fully funded with equity investment. Lyten, the global leader in lithium-sulfur batteries, announced today that it has entered into a binding agreement to acquire Northvolt’s remaining assets in Sweden and Germany. The acquisition includes Northvolt Ett and Ett Expansion (Skellefteå, Sweden), Northvolt Labs (Västerås, Sweden), and Northvolt Drei (Heide, Germany). Additionally, Lyten is ac
Energy Vault Secures Final FIRB Approval and Completes Acquisition of 125 MW/1,000 MWh Stoney Creek BESS in Australia7.8.2025 15:15:00 CEST | Press release
Stoney Creek represents first acquisition in Australia as part of Energy Vault’s global “Own & Operate” portfolio and reinforces long-term commitment to Australia’s energy transition125 MW/1,000 MWh Stoney Creek BESS set to support grid reliability and flexibility while advancing the energy transition in New South Wales, supported by a 14-year offtake agreementStoney Creek is Energy Vault’s third and largest Energy Storage Asset in the portfolio, following the successful completion of the Cross Trails BESS in Texas and Calistoga Resiliency Center in California, and is expected to deliver ~$30 million in combined annual, recurring EBITDA for the next 15+ years Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault"), a global leader in grid-scale energy storage solutions, today announced it has received Foreign Investment Review Board (FIRB) approval and completed the full acquisition of the Stoney Creek Battery Energy Storage System (BESS) project in Northern New South Wales. The 125
Museum Centre Vapriikki:Ancient DNA Reveals 800-year-old Family Link in Medieval Finland7.8.2025 14:05:00 CEST | Press release
Ancient DNA research led by the Museum Centre Vapriikki in Tampere, Finland, in collaboration with the universities of Turku and Helsinki, has produced new insights into kinship, health, and population continuity in medieval and early modern Finland. Published in the peer-reviewed journal iScience, the research presents results from 25 individuals in Finland – a significant result in a country where acidic soils often lead to poor preservation of bones and genetic material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250807066724/en/ The woman’s grave in Vilusenharju, Tampere was discovered in 1962, and the man’s grave in Ristiänmäki, Pälkäne in 1982. Ancient DNA research has now revealed that the deceased were siblings. Illustrations by Veronika Paschenko. Photo by Vapriikki. Researchers successfully recovered DNA from individuals buried between the 12th and 19th centuries at three cemeteries in the Tampere region. The s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom